financetom
Business
financetom
/
Business
/
What's Going On With D-Wave Quantum Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With D-Wave Quantum Stock Today?
Feb 13, 2025 4:39 AM

D-Wave Quantum Inc. ( QBTS ) revealed that it is enabling research centers, academic institutions, and governments to purchase on-premises D-Wave Advantage quantum computing systems.

This move aims to empower organizations to push the boundaries of quantum experimentation and development, with applications focussing quantum simulation.

D-Wave’s Advantage system, with over 5,000 qubits and 15-way connectivity, is already available for on-premises installation.

The flexibility to integrate with classical and high-performance computing systems allows organizations to fine-tune parameters and take advantage of new innovations as they emerge.

According to the company’s statement, D-Wave vice president of infrastructure Irwan Owen is leading the systems’ go-to-market effort.

According to Benzinga Pro, QBTS stock has gained over 319% in the past year. Investors can gain exposure to the stock via Defiance Quantum ETF ( QTUM ) .

Also Read: Tesla Stock Climbs Over 2% In Thursday Pre-Market: What’s Going On?

In a separate press release, D-Wave Quantum ( QBTS ), and the Jülich Supercomputing Centre at Forschungszentrum Jülich, or FZJ announced that FZJ has purchased a D-Wave quantum ( QBTS ) computer.

This makes FZJ the first high-performance computing center in the world to own a D-Wave Advantage annealing quantum system.

Additionally, D-Wave has launched the “Quantum Uplift” program to address dissatisfaction with competitor systems, offering incentives to organizations seeking a reliable and performant quantum solution.

Price Action: QBTS shares are trading higher by 1.99% to $6.160 premarket at last check Thursday.

Read Next:

 Mitch McConnell Criticizes Trump’s Tariff Plans, Warns Of Potential Price Hike: ‘Big, Lingering Concerns For American Industry And Workers’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Spectaire (SPEC) Stock Is Popping Off
Why Spectaire (SPEC) Stock Is Popping Off
Apr 17, 2024
Spectaire Holdings Inc ( SPEC ) shares are trading higher by 15% to $0.92 during Wednesday’s session after the company announced that it signed a distribution partnership agreement with a Fortune 1000 Energy Company. What Happened? Spectaire ( SPEC ) has signed a distribution partnership with a Fortune 1000 Energy Company, granting them global distribution rights for Spectaire’s AireCore units...
What's Going On With CXAI Stock?
What's Going On With CXAI Stock?
Apr 17, 2024
CXApp Inc. ( CXAI ) shares are trading higher Wednesday after the company announced record double digit Annual Recurring Revenue (ARR) growth in the fourth quarter of 2023 and 24% ARR growth for the full year 2023. The Details: The company also announced it is rebranding to CXAI, pronounced “sky.” CXAI stated the rebranding signifies a shift towards an AI-centric...
Constellation seeks 20-year license extension for Dresden nuclear plant
Constellation seeks 20-year license extension for Dresden nuclear plant
Apr 17, 2024
April 17 (Reuters) - Constellation Energy Corp ( CEG ) said on Wednesday it has asked the U.S. Nuclear Regulatory Commission (NRC) to extend the operating license of its Dresden plant in Illinois by another two decades. The nuclear plant produces enough baseload electricity to power the equivalent of nearly 1.4 million homes, and is currently licensed to operate through...
NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise
NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise
Apr 17, 2024
11:21 AM EDT, 04/17/2024 (MT Newswires) -- NeuroBo Pharmaceuticals ( NRBO ) said Wednesday the first patient has been dosed in part 1 of its two-part early-stage trial of DA-1726 for the treatment of obesity. The company said part 1 of the study will enroll about 45 participants and part 2 about 36 participants, with dosing of first patient in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved